Published in AIDS Weekly, October 30th, 2006
This rapid, point-of-care test, which is U.S. Food and Drug Administration (FDA)-cleared, utilizes StatSure's patented barrel technology, designed to provide safe, accurate and integrated single-use, rapid HIV antibody screening, and to minimize exposure to infectious agents; it will be exclusively manufactured by Chembio for Inverness'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.